Metsera's obesity drug shows promising weight loss in mid-stage trials

Sept 29 (Reuters) – Metsera said on Monday that its experimental obesity drug showed significant weight loss and favorable tolerability in mid-stage studies. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)